Darinaparsin Completed Phase 2 Trials for Neoplasms, Hematologic / Bone Marrow Neoplasms / Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00421213Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers